IPP Bureau
GL Chemtech partners with Edgewater Capital to accelerate growth
By IPP Bureau - August 12, 2022
Investment in response to increased demand for North American-based chemistry services
Hikal shows 17% degrowth in Q1 FY23
By IPP Bureau - August 12, 2022
Pharmaceutical sales de-grew 18% YoY and stood at Rs. 224 crore whereas Crop Protection sales de-grew by 15% at Rs. 154 crore
IOL Chemicals and Pharmaceuticals reports Q1 FY23 revenue of Rs. 570.2 Cr
By IPP Bureau - August 12, 2022
The company will strengthen its position in the ‘green solvent’ market by increasing its capacity by 20% to 120,000 MTPA from 100,000 MTPA before the end of current fiscal
Apollo Hospitals posts Q1 FY23 consolidated PAT at Rs. 317.11 Cr
By IPP Bureau - August 12, 2022
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
ShilpaMedicare Q1FY23 consolidated PAT drops to to Rs. 84.85 lakhs
By IPP Bureau - August 12, 2022
Kaléo announces appointments and new government business unit
By IPP Bureau - August 12, 2022
Aurobindo Pharma posts consolidated Q1FY23 PAT of Rs. 520.54 Cr
By IPP Bureau - August 12, 2022
The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022.
S. Sridhar resigns as Managing Director of Pfizer
By IPP Bureau - August 11, 2022
Sridhar will continue to serve in his current position of Managing Director for as long a period as required until the identification, selection and transition to the new leadership takes place in the company.
Lincoln Pharmaceuticals Q1 FY23 consolidated profit up at Rs. 15.01 Cr
By IPP Bureau - August 11, 2022
The company has reported total income of Rs. 129.96 crores during the period ended June 30, 2022.
Agriculture Minister Narendra Singh Tomar launches indigenous vaccine for Lumpy Skin disease
By IPP Bureau - August 11, 2022
The vaccine has been developed by the National Equine Research Center, Hisar (Haryana) in collaboration with the Indian Veterinary Research Institute, Izzatnagar (Bareilly)
IPCA Laboratories Q1 FY23 consolidated PAT higher at Rs. 143.06 Cr
By IPP Bureau - August 11, 2022
The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022.
Max Healthcare Institute Q1 FY23 consolidated PAT soars at Rs. 172.83 Cr
By IPP Bureau - August 11, 2022
The company has reported total income of Rs. 1097.78 crores during the period ended June 30, 2022.
Zydus Lifesciences Q1 FY23 consolidated PAT up at Rs. 518.3 Cr
By IPP Bureau - August 11, 2022
The company has reported total income of Rs. 4138.6 crores during the period ended June 30, 2022.
AI to shape future outcomes in cardiovascular care, says GlobalData
By IPP Bureau - August 11, 2022
AI-driven company anumana partnered with Novartis to drive the development of its electrocardiogram (ECG) AI algorithms to detect subclinical heart disease.
Vijaya Diagnostic Centre Q1 FY23 revenue down 14.9%
By IPP Bureau - August 10, 2022
EBITDA stood at Rs. 39.9 crore and EBITDA margin for the quarter was 38.2% whereas Profit After Tax (PAT) stood at Rs. 17.5 crore translating into a PAT margin of 16.7%
